Find XO: Mediwhale Raises 20 Billion Won and Heads to FDA (venturesquare.net)

- Mediwhale has secured 20 billion won in Series C funding. - The investment will be used to pursue U.S. FDA approval for the cardiovascular diagnostic device Dr. NUN CVD and to expand domestic and international markets. - This serves as a case for medical device founders to consider how early product development and regulatory preparation should be aligned when planning overseas expansion. - If clinical data needs to be re-prepared after checking approval requirements right before launch, financial plans can also become complicated.